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 Purpose: To investigate the association between radiologist in-
terpretive volume and diagnostic mammography perfor-
mance in community-based settings.
 Materials and 
Methods: 
This study received institutional review board approval 
and was HIPAA compliant. A total of 117 136 diagnostic 
mammograms that were interpreted by 107 radiologists 
between 2002 and 2006 in the Breast Cancer Surveillance 
Consortium were included. Logistic regression analysis 
was used to estimate the adjusted effect on sensitivity 
and the rates of false-positive fi ndings and cancer detec-
tion of four volume measures: annual diagnostic volume, 
screening volume, total volume, and diagnostic focus (per-
centage of total volume that is diagnostic). Analyses were 
stratifi ed by the indication for imaging: additional imaging 
after screening mammography or evaluation of a breast 
concern or problem.
 Results: Diagnostic volume was associated with sensitivity; the 
odds of a true-positive fi nding rose until a diagnostic vol-
ume of 1000 mammograms was reached; thereafter, they 
either leveled off ( P  , .001 for additional imaging) or de-
creased ( P = .049 for breast concerns or problems) with 
further volume increases. Diagnostic focus was associated 
with false-positive rate; the odds of a false-positive fi nding 
increased until a diagnostic focus of 20% was reached and 
decreased thereafter ( P  , .024 for additional imaging and 
 P  , .001 for breast concerns or problems with no self-
reported lump). Neither total volume nor screening volume 
was consistently associated with diagnostic performance.
 Conclusion: Interpretive volume and diagnostic performance have 
complex multifaceted relationships. Our results suggest 
that diagnostic interpretive volume is a key determinant in 
the development of thresholds for considering a diagnos-
tic mammogram to be abnormal. Current volume regula-
tions do not distinguish between screening and diagnostic 
mammography, and doing so would likely be challenging.
 q RSNA, 2011
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part by several state public health depart-
ments and cancer registries through-
out the United States. For a full descrip-
tion of these sources, please see  http:
//breastscreening.cancer.gov/work
/acknowledgement.html . The authors 
had full responsibility for designing the 
study; collecting, analyzing, and inter-
preting the data; writing the manuscript; 
and deciding to submit it for publication. 
 The Breast Cancer Surveillance 
Consortium (BCSC) is a population-based 
collaborative network of mammography 
registries ( 14,15 ). Each registry col-
lects demographic and clinical data at 
each mammography visit at participat-
ing facilities. Cancer outcomes are as-
certained via linkage to a regional or 
Surveillance, Epidemiology, and End 
Results cancer registry and to pathol-
ogy databases. Analyses presented here 
are based on pooled data from six 
registries (San Francisco, Calif; North 
Carolina; New Hampshire; Vermont; 
western Washington; and New Mexico). 
Sites received institutional review board 
approval for study activities and for 
protection of the identities of women, 
to understanding variability in the inter-
pretive performance of diagnostic mam-
mography in community-based settings. 
Despite studies in which researchers 
considered characteristics at the level of 
the woman and mammogram ( 1,3–8 ), 
radiologist ( 9,10 ), and facility ( 11–13 ), 
broad unexplained variation remains in 
the performance of diagnostic mam-
mography ( 1,9 ). 
 One possible source of variation in 
performance is the interpreting radi-
ologist’s volume of work; an Institute of 
Medicine report called for more research 
in this area ( 2 ). To our knowledge, in 
only two studies have researchers ex-
amined interpretive volume as it relates 
to diagnostic mammography. Jensen et al 
( 13 ) noted improved diagnostic perfor-
mance in Danish clinics with at least 
one radiologist with a high volume of 
work. However, they did not examine 
radiologist-specifi c volume measures. 
Miglioretti et al ( 9 ) found no associ-
ation between work volume and diag-
nostic performance, but the evaluation 
was limited by the use of a self-reported 
three-level categorical measure of to-
tal volume. Given these limitations, we 
undertook this study to investigate the 
association between radiologist inter-
pretive volume and diagnostic mam-
mography performance in community-
based settings. 
 Materials and Methods 
 The collection of cancer incidence data 
used in this study was supported in 
 D iagnostic mammography is a crit-ical tool in the evaluation of ab-normal screening mammograms 
and in the examination of women who 
have signs or symptoms of breast can-
cer. Unlike screening mammography, 
diagnostic mammography usually in-
volves acquisition of additional mammo-
graphic images, is typically performed 
to evaluate a specifi c area of concern, 
and frequently involves a population in 
which cancer is approximately 10 times 
more prevalent than in the general pop-
ulation ( 1 ). 
 The technical quality of mammog-
raphy has improved since the 1992 Mam-
mography Quality Standards Act ( 2 ); 
however, relative to screening mammog-
raphy, little research has been devoted 
 Implication for Patient Care 
 Our results suggest that diagnos- n
tic interpretive volume is a key 
determinant in developing 
thresholds for considering a diag-
nostic mammogram to be abnor-
mal; however, because of the 
complex and multifaceted nature 
of interpretive volume and diag-
nostic performance, it is diffi cult 
to characterize their relationship, 
which limits the practicality of 
setting regulatory thresholds for 
diagnostic mammographic 
interpretation. 
 Advances in Knowledge 
 Neither annual total volume nor  n
screening volume was consis-
tently associated with diagnostic 
performance. 
 Annual diagnostic volume exhib- n
ited a strong association with 
sensitivity of diagnostic mam-
mography performed for addi-
tional imaging or for evaluation 
of breast concerns or problems 
( P  , .001 and  P = .049, 
respectively). 
 For diagnostic mammography  n
performed to evaluate breast 
concerns or problems, signifi cant 
interactions between diagnostic 
focus and the presence of a self-
reported lump were found for 
each performance measure ( P = 
.020,  P  , .001, and  P = .027 for 
sensitivity, false-positive rate, 
and cancer detection rate, 
respectively). 
 False-positive rate exhibited an  n
increasing association with diag-
nostic focus up to a focus of 
20%; beyond this apex, false-
positive rate decreased with in-
creasing diagnostic focus. 
 No consistent association was  n
found between any volume 
measure and cancer detection 
rate. 
 Published online before print 
 10.1148/radiol.11111026 Content code:  
Radiology 2012; 262:69–79
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 BCSC = Breast Cancer Surveillance Consortium 
 CDR = cancer detection rate 
 CI = confi dence interval 
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mammograms; and diagnostic focus, 
1%–40%. 
 To estimate the adjusted effect of 
volume on diagnostic performance, we 
fi t separate logistic regression models 
for each performance measure. Models 
for sensitivity included mammograms 
obtained in patients in whom a cancer 
diagnosis was made within 1 year after 
mammography, with fi nal assessment 
(positive or negative) as the outcome. 
Models for FPR were also used in the fi -
nal assessment but were based on mam-
mograms obtained in patients in whom 
no cancer diagnosis was made within 
1 year after mammography. Models 
for CDR included all mammograms and 
used the outcome of whether cancer 
was diagnosed within 1 year after pos-
itive fi nal assessment. All models were 
adjusted for BCSC registry. Patient-level 
characteristics were age, family history, 
self-reported presence of a lump, and 
time since last mammographic exami-
nation. Radiologist-level characteristics 
were years of experience with mammo-
gram interpretation and percentage of 
time spent in breast imaging. Breast 
density was not included because of the 
high rate of missing data. 
 To avoid making restrictive assump-
tions about the shape of the volume-
performance relationships, we used natu-
ral cubic splines with one knot at the mid-
point of the prespecifi ed volume ranges 
( 22 ). To standardize interpretations, 
we set the following reference levels: 
2000 mammograms for total volume, 
1500 mammograms for screening vol-
ume, 1000 mammograms for diagnostic 
volume, and 20% for diagnostic focus. 
The tables show estimated adjusted odds 
ratios and 95% CIs; Appendix E1 (on-
line) provides additional detail. 
 We hypothesized that a self-reported 
lump could modify the effect of volume 
on interpretive performance for mam-
mograms that showed a breast concern 
or problem. Thus, we tested for an inter-
action between self-reported lump and 
each volume measure. For volume and 
performance combinations with signifi cant 
interactions, we present lump stratum–
specifi c results; otherwise, we present 
results from the main effects–only model 
(with adjustment for self-reported lump). 
diagnostic focus is the percentage of 
total mammograms that were considered 
diagnostic. 
 Interpretive Performance 
 We included diagnostic mammograms 
that had indications for additional imag-
ing of an abnormality that was detected 
at screening or that were obtained to 
evaluate a breast concern or problem ( 1 ). 
Mammograms obtained in women with 
a history of breast cancer were excluded. 
 Examination results were considered 
positive or negative on the basis of the 
fi nal Breast Imaging Reporting and Data 
System assessment at the end of imaging 
work-up (up to 90 days after acquisition 
of the index diagnostic mammogram 
and before biopsy) with use of standard 
BCSC defi nitions ( 20 ). Women were 
considered to have breast cancer if a 
diagnosis of invasive carcinoma or duc-
tal carcinoma in situ was made within 
1 year after mammography. 
 Performance measures included sen-
sitivity, false-positive rate (FPR) per 100 
mammograms, and cancer detection rate 
(CDR) per 1000 mammograms ( 15 ). 
 Statistical Analyses 
 All analyses were stratifi ed by indica-
tion. Volume measures were analyzed 
in relation to performance in the subse-
quent year. For instance, 2005 volume 
was linked to 2006 performance ( 18 ). 
 We examined the distributions of 
radiologist- and mammogram-level char-
acteristics with categorized volume mea-
sures. To describe overall performance, 
we calculated performance measures 
for each radiologist collapsing across all 
examinations and years. We examined 
unadjusted associations by estimating 
performance by using all mammograms 
within each categorized volume stratum 
and calculating 95% confi dence intervals 
(CIs) ( 21 ). 
 The observed volume distributions 
were heavily skewed, with sparse in-
formation at very high volumes. To en-
sure stable estimation, we restricted our 
modeling to mammograms with annual 
average volume measures in the following 
ranges: total volume, 480–7000 mam-
mograms ; screening volume, 480–6000 
mammograms; diagnostic volume, 0–2500 
physicians, and facilities. Radiologists 
provided informed consent. Active con-
sent, passive permission, and/or waivers 
were obtained at each BCSC site from 
women who underwent mammography. 
Procedures were compliant with the 
Health Insurance Portability and Account-
ability Act ( 16 ). 
 Interpretive Volume 
 Between 2005 and 2006, 214 BCSC radi-
ologists who interpreted mammograms 
at a BCSC facility completed a self-
administered mailed survey ( 17 ). The 
survey asked radiologists to indicate all 
facilities where they had interpreted 
mammograms between 2001 and 2005. 
For each radiologist who interpreted 
mammograms at non-BCSC facilities, 
registry staff collected additional vol-
ume information at the non-BCSC fa-
cilities. Only radiologists with complete 
volume information from all facilities 
were included. Our fi nal study sample 
included 107 radiologists; demographic 
characteristics and experience of these 
radiologists resembled those of the 
original survey respondents (Table E1 
[online]). 
 We measured diagnostic volume, 
screening volume, and total volume when 
the radiologist served as the primary 
reader from each facility for each year 
between 2001 and 2005. Diagnostic vol-
ume included examinations performed 
for additional evaluation of a prior mam-
mogram, short-interval follow-up, or 
evaluation of a breast concern or prob-
lem. Total volume included all diagnostic 
and screening examinations; diagnostic 
and screening mammograms obtained 
in the same woman and interpreted by 
the same radiologist on the same day 
counted as one study ( 18 ). This differs 
from Breast Imaging Reporting and Data 
System audits ( 19 ), where screening and 
diagnostic mammography performed 
on the same day independently contrib-
ute to total volume. Mammograms with 
missing indication (2.5%) were attrib-
uted to diagnostic or screening volume 
based on the observed proportion for 
that reader ( 18 ). 
 For each radiologist and year, each 
volume measure was summed across 
all facilities to obtain annual totals; 
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 Table 1 
 Distribution of Radiologist Characteristics across 107 Radiologists by Average Annual Diagnostic Volume 
Characteristic
Overall 
Distribution
Average Annual Diagnostic Volume
 , 100 
Mammograms
100–199 
Mammograms
200–299 
Mammograms
300–499 
Mammograms
500–999 
Mammograms
  1000 
Mammograms
Overall distribution 14 10 22 32 11 10
Demographics
 Age at survey (y)
   , 45 24 20 18 38 24 33 0
  45–54 29 27 9 25 29 50 36
    55 47 53 73 38 47 17 64
 Sex
  Male 66 87 64 88 59 42 45
  Female 34 13 36 12 41 58 55
 Works full time (  40 h/wk)
  No 25 27 36 9 27 25 36
  Yes 75 73 64 91 73 75 64
  Unknown 2 0 0 4 3 0 0
 Affi liation with academic medical center
  No affi liation 73 60 64 88 88 50 40
  Adjunct 8 13 0 12 3 0 30
  Primary 19 27 36 0 9 50 30
  Unknown 1 0 0 0 0 0 9
Experience
 Time since graduated residency (y)
   , 10 16 7 18 29 12 25 0
  10–19 30 27 18 29 39 17 36
    20 54 67 64 42 48 58 64
  Unknown 1 0 0 0 3 0 0
 Combined variable of fellowship training and 
   duration of mammogram interpretation (y)
  No fellowship,  , 10 17 20 18 25 19 0 0
  No fellowship, 10–19 32 13 27 42 41 18 33
  No fellowship,   20 48 67 55 33 41 55 67
  Fellowship,  , 10 3 0 0 0 0 27 0
  Fellowship,   10 5 0 0 0 6 8 18
 Time working in breast imaging (%)
   , 20 26 29 30 52 21 8 0
  20–39 25 14 40 30 36 8 0
  40–79 15 7 10 0 15 58 9
  80–100 34 50 20 17 27 25 91
  Unknown 4 7 9 4 3 0 0
Interpretive volume
 Average annual screening volume
   , 480 mammograms 3 20 0 0 0 0 0
  480–999 mammograms 26 53 64 42 9 0 0
  1000–1499 mammograms 16 13 27 21 21 0 0
  1500–1999 mammograms 23 7 0 33 41 17 0
  2000–2999 mammograms 13 7 0 4 21 33 9
    3000 mammograms 19 0 9 0 9 50 91
 Average annual total volume
   , 480 mammograms 2 13 0 0 0 0 0
  480–999 mammograms 16 53 55 12 0 0 0
  1000–1499 mammograms 22 20 36 46 18 0 0
  1500–1999 mammograms 13 7 0 21 24 0 0
Table 1 (continues)
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Characteristic
Overall 
Distribution
Average Annual Diagnostic Volume
 , 100 
Mammograms
100–199 
Mammograms
200–299 
Mammograms
300–499 
Mammograms
500–999 
Mammograms
  1000 
Mammograms
  2000–2999 mammograms 22 0 0 21 47 25 0
  3000–4999 mammograms 14 7 9 0 9 58 27
    5000 mammograms 10 0 0 0 3 17 73
 Average annual diagnostic focus (%)
    10 20 80 36 12 6 0 0
  11–15 23 13 27 46 18 17 9
  16–20 36 7 27 33 53 58 9
  21–25 12 0 9 4 18 8 36
   . 25 9 0 0 4 6 17 45
 Average annual no. of facilities where 
   mammograms were interpreted
  1 30 27 45 42 18 33 27
   . 1–2 45 67 36 25 50 50 45
   . 2–3 14 7 18 17 21 8 0
   . 3 11 0 0 17 12 8 27
 Amount of volume and performance data (y)
  1 7 13 18 8 6 0 0
  2 7 20 9 4 0 17 0
  3 16 20 27 21 3 17 27
  4 21 27 9 12 26 33 9
  5 50 20 36 54 65 33 64
Note.—All data are percentages. Unknown percentages are based on all 107 radiologists; remaining percentages are based on the number with the characteristic known.
Table 1 (continued)
 Distribution of Radiologist Characteristics across 107 Radiologists by Average Annual Diagnostic Volume 
 Generalized estimating equations 
were used to estimate model param-
eters ( 23,24 ). To account for within-
radiologist correlation, we adopted a 
working exchangeable correlation struc-
ture and calculated standard errors, 
two-sided  P values, and 95% CIs with 
the robust sandwich estimator ( 23 ). 
Sensitivity analyses included individually 
excluding each registry to ensure none 
overly infl uenced results, not adjusting 
for radiologist-level characteristics, and 
adjusting for breast density. Statistical 
signifi cance was based on two-sided 
 P values at the .05 level. All analyses were 
performed by using R software (version 
2.12.0; R Foundation for Statistical 
Computing, Vienna, Austria) ( 25 ). 
 Results 
 Our study included 107 radiologists who 
interpreted 117 136 diagnostic mam-
mograms (46 369 obtained because ad-
ditional imaging was required, 70 767 
obtained because of a breast concern 
or problem) obtained in 98 667 women. 
Most radiologists (86%) contributed at 
least 3 years of volume data, perfor-
mance data, or both (50% contributed 
5 years of volume data), for a total of 
426 reader-years. 
 The median age of radiologists was 
54 years (age range, 37–72 years); most 
radiologists were men (66%), worked 
full time (75%), and had interpreted 
mammograms for at least 10 years (84%) 
( Table 1 ). Approximately 34% of the 
radiologists spent most (80%–100%) 
of their time working in breast imag-
ing. The median average annual diag-
nostic volume was 315 mammograms; 
15 (14%) of the 107 radiologists inter-
preted fewer than 100 diagnostic mammo-
grams on average; 11 (10%) interpreted 
at least 1000 mammograms. Read ers 
with the highest average annual diag-
nostic volume (  1000 mammograms) 
were more likely to be women (55%, 
compared with 34% overall), spend more 
time in breast imaging (91% spend 80%–
100% of their time in breast imaging, 
compared with 34% overall), and have 
higher total and screening volume and a 
higher diagnostic focus ( Table 1 ). 
 Table 2 presents characteristics of 
women who underwent mammography 
for the purpose of additional imaging 
or to evaluate a breast concern or prob-
lem; Tables E2 and E3 (online) present 
this information stratifi ed by diagnostic 
volume. A greater proportion of mam-
mograms were obtained to evaluate a 
breast concern or problem in women 
aged at least 40 years (17%, compared 
with 4% for additional imaging mam-
mography). Only 2% of the 42 526 
mammograms obtained for additional 
imaging that were not missing symptom 
information revealed a lump compared 
with 33% of the 65 691 mammograms 
obtained because of a breast concern or 
problem that had nonmissing symptom 
information. Eighteen percent of mam-
mograms obtained in patients who were 
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not missing self-reported family history 
indicated a positive prior history. 
 Table 3 presents unadjusted per-
formance estimates across categorized 
volume measures. No consistent patterns 
emerged for additional imaging mam-
mography. For mammography performed 
because of a breast concern or prob-
lem, sensitivity increased as average 
annual diagnostic volume and diagnos-
tic focus increased. Further, CDR de-
creased with increased average annual 
total volume, screening volume, and di-
agnostic volume. 
 In adjusted analyses, diagnostic vol-
ume was signifi cantly ( P  , .001) as-
sociated with sensitivity for additional 
imaging mammography ( Table 4 , Fig E4 
[online]); the estimated odds ratios 
were bell shaped, with an apex at 1000 
mammograms. When we compared diag-
nostic volumes of 1500 and 1000 mam-
mograms, the estimated odds ratio was 
0.82 (95% CI: 0.69, 0.99); that is, the 
odds of a true-positive assessment for 
an additional imaging mammogram in-
terpreted by a radiologist with a diag-
nostic volume of 1500 mammograms 
are approximately 18% lower than those 
for a radiologist with a diagnostic vol-
ume of 1000 mammograms. When we 
compared a diagnostic volume of 2000 
mammograms with a diagnostic volume 
of 1000 mammograms, the estimated 
odds ratio for sensitivity decreased to 
0.43 (95% CI: 0.29, 0.64). When we 
decreased diagnostic volume to 300 mam-
mograms, the estimated odds ratio for 
sensitivity compared with 1000 mam-
mograms decreased to 0.65 (95% CI: 
0.35, 1.19). There was insuffi cient evi-
dence of an association between diag-
nostic volume and FPR ( P = .20) or 
CDR ( P = .061). 
 Mammography performed to eval-
uate a breast concern or problem re-
vealed no interaction between diagnos-
tic volume and self-reported lump for 
sensitivity ( P = .27) or CDR ( P = .20); 
for FPR, the interaction was signifi -
cant ( P = .011). On the basis of a main 
effects–only model, the association be-
tween diagnostic volume and sensitiv-
ity increased until a diagnostic volume 
of approximately 1500 mammograms 
was reached; thereafter, the association 
 Table 2 
 Distribution of Patient and Radiologist Characteristics for Mammograms Obtained for 
Additional Imaging and for Breast Concern or Problem 
Characteristic
Additional Imaging 
( n = 46 369)
Breast Concern or Problem 
( n = 70 767)
Patient-level characteristics
 Age (y)
   , 40 1694 (4) 11 973 (17)
  40–49 16 132 (35) 20 219 (29)
  50–59 14 243 (31) 17 913 (25)
  60–69 7994 (17) 10 749 (15)
  70–79 4578 (10) 6769 (10)
    80 1728 (4) 3144 (4)
 Breast density
  Almost entirely fat 1783 (5) 4250 (9)
  Scattered fi broglandular tissue 15 534 (40) 18 064 (37)
  Heterogeneously dense 19 063 (49) 20 706 (43)
  Extremely dense 2403 (6) 5466 (11)
  Unknown 7586 (16) 22 281 (31)
 First-degree family history
  No 33 892 (82) 51 605 (82)
  Yes 7217 (18) 11 247 (18)
  Unknown 5260 (11) 7915 (11)
 Self-reported lump
  No 41 555 (98) 43 788 (67)
  Yes 971 (2) 21 903 (33)
  Unknown 3843 (8) 5076 (7)
 Time since last mammography (mo)
  No previous mammography 3706 (8) 6307 (10)
   , 12 1918 (4) 20 283 (32)
  12–35 33 201 (75) 31 112 (49)
  35–59 3022 (7) 3519 (5)
    60 2176 (5) 2785 (4)
  Unknown 2346 (5) 6761 (10)
Radiologist-level characteristics
 Average annual diagnostic volume
   , 100 mammograms 853 (2) 1044 (1)
  100–199 mammograms 1219 (3) 1340 (2)
  200–299 mammograms 6645 (14) 4814 (7)
  300–499 mammograms 14 398 (31) 13 984 (20)
  500–999 mammograms 8028 (17) 9230 (13)
    1000 mammograms 15 226 (33) 40 355 (57)
 Average annual screening volume
   , 480 mammograms 122 (0) 105 (0)
  480–1000 mammograms 5073 (11) 3111 (4)
  1000–1499 mammograms 5361 (12) 4154 (6)
  1500–1999 mammograms 9153 (20) 9429 (13)
  2000–2999 mammograms 8257 (18) 15 447 (22)
    3000 mammograms 18 403 (40) 38 521 (54)
 Average annual total volume
   , 480 mammograms 17 (0) 6 (0)
  480–1000 mammograms 1890 (4) 1494 (2)
  1000–1499 mammograms 6326 (14) 4259 (6)
  1500–1999 mammograms 5018 (11) 4135 (6)
  2000–2999 mammograms 10 962 (24) 11 241 (16)
Table 2 (continues)
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Table 2 (continued)
Distribution of Patient and Radiologist Characteristics for Mammograms Obtained for 
Additional Imaging and for Breast Concern or Problem
Characteristic
Additional Imaging 
( n = 46 369)
Breast Concern or Problem 
( n = 70 767)
  3000–4999 mammograms 9976 (22) 12 141 (17)
    5000 mammograms 12 180 (26) 37 491 (53)
 Average annual diagnostic focus (%)
    10 2287 (5) 3694 (5)
  11–15 6350 (14) 6862 (10)
  16–20 18 307 (39) 15 960 (23)
  21–25 11 947 (26) 10 497 (15)
   . 25 7478 (16) 33 754 (48)
Note.—Data are numbers of mammograms, and data in parentheses are percentages. Unknown percentages are based on all 
mammograms; remaining percentages are based on mammograms with the characteristic known.
reached a plateau ( P = .049) ( Table 4, 
Figure E4 [online]). Given the signif-
icant interaction, results for FPR have 
been stratifi ed according to self-reported 
lump. For women who did not report a 
lump, diagnostic volume was associated 
with FPR for mammography performed 
to evaluate a breast concern or problem 
( P = .004). The estimated association 
was bell shaped, increased to an apex 
of approximately 1100 mammograms, 
and then decreased. In women who 
reported a lump, we detected no asso-
ciation ( P = .58). CDR displayed no evi-
dence of an association with diagnostic 
volume for mammography performed 
because of a breast concern or problem 
( P = .24). 
 For additional imaging mammogra-
phy, diagnostic focus exhibited a mar-
ginal association with sensitivity ( P = 
.055) and signifi cant associations with 
FPR ( P = .024) and CDR ( P = .007) 
( Table 5 , Fig E5 [online]). For both 
sensitivity and FPR, the estimated odds 
ratio curve is bell shaped, increasing to 
apexes of 18% and 23%, respectively, 
and then decreasing. When we com-
pared diagnostic focuses of 10% and 
20%, the estimated adjusted odds ratio 
for FPR was 0.85 (95% CI: 0.75, 0.97). 
That means the odds of a false-positive 
assessment for an additional imaging 
mammogram interpreted by a radiol-
ogist with a diagnostic focus of 10% 
were approximately 15% lower than the 
odds of a false-positive assessment for 
an additional imaging mammogram in-
terpreted by a radiologist with 20% di-
agnostic focus. When we compared two 
additional imaging mammograms inter-
preted by radiologists with diagnostic 
foci of 5% and 20%, the odds ratio for 
FPR decreased to 0.75 (95% CI: 0.60, 
0.94). For CDR, the estimated odds ra-
tio curve increased linearly from 0.83 
to 1.33, respectively, when we compared 
diagnostic foci of 5% and 40% with a 
focus of 20% 
 For all three performance measures, 
the interaction between diagnostic fo-
cus and self-reported lump in mammog-
raphy performed to address a breast 
concern or problem was signifi cant ( P = 
.020,  P  , .001, and  P  , .027 for sen-
sitivity, FPR, and CDR, respectively). 
Among women who did not report a 
lump, the association between diagnos-
tic focus and both sensitivity and FPR 
was bell shaped ( Table 5 , Fig E5 [on-
line]); only the association with FPR 
was signifi cant ( P  , .001). For CDR, 
the estimated odds ratio curve linearly 
decreased from 1.27 to 0.87, respec-
tively, when we compared diagnostic 
foci of 5% and 40% with a focus of 
20%; however, this difference was not 
signifi cant ( P = .293). Among women 
who reported a lump, diagnostic focus 
was marginally associated with sensitiv-
ity ( P = .051); when compared with a 
focus of 20%, increasing the diagnostic 
focus from 5% to 30% corresponded to 
an estimated odds ratio increase (from 
0.58 [95% CI: 0.31, 1.09] to 1.47 [95% 
CI: 0.79, 2.75]). 
 While not signifi cant, there was bor-
derline evidence of an increasing asso-
ciation between screening volume and 
FPR for both additional imaging mam-
mography ( P = .098) and breast con-
cern or problem mammography ( P = 
.076) (Table E5, Fig E6 [online]). There 
were nonlinear associations between 
screening volume and sensitivity among 
women who underwent mammography 
to address a breast concern or prob-
lem. In women who did not report a 
lump, the estimated association was 
bell-shaped, with an apex at approxi-
mately 3000 mammograms ( P = .003); 
in women who did report a lump, the 
estimated association increased until 
approximately 4000 mammograms and 
then plateaued ( P = .148). For CDR, 
we found no evidence of an associa-
tion with screening volume. Neither 
indication had consistent evidence of 
a relationship between total volume 
and diagnostic performance (Table E6 
[online]). 
 The clinical interpretation of results 
did not change after we completed the 
sensitivity analyses described previously. 
 Discussion 
 We found that diagnostic volume and 
diagnostic focus were most consistently 
associated with performance; neither 
screening volume nor total volume was 
consistently associated with performance. 
For diagnostic volume and diagnostic 
focus, the associations were approxi-
mately quadratic: Radiologists with ei-
ther low volume/focus or high volume/
focus had the lowest FPR; radiologists 
with an annual diagnostic volume of ap-
proximately 1000 mammograms or a 
diagnostic focus of approximately 20% 
had the highest FPR. In parallel, radi-
ologists with either low volume/focus or 
high volume/focus had the lowest sensitiv-
ity, indicating an important tradeoff be-
tween the two performance measures. 
These results generally held for both 
additional imaging and breast concern 
or problem diagnostic mammography. 
In contrast, CDR for additional imag-
ing mammography increased linearly as 
76 radiology.rsna.org n Radiology: Volume 262: Number 1—January 2012
 BREAST IMAGING: Mammographic Interpretive Volume Haneuse et al
 Table 3 
 Unadjusted Diagnostic Performance Measure Estimates across Categorized Volume Measures, Stratifi ed by Indication 
Volume and Focus
Additional Imaging Evaluation of a Breast Concern or Problem
Sensitivity FPR CDR Sensitivity FPR CDR
Average annual diagnostic volume
  , 100 mammograms 85.6 (77.3, 91.8) 9.4 (8.2, 10.6) 32.5 (25.8, 40.1) 83.8 (76.2, 89.8) 7.6 (6.6, 8.7) 36.7 (29.8, 44.5)
 100–199 mammograms 81.0 (61.1, 93.7) 11.4 (8.6, 14.6) 36.9 (22.2, 56.7) 83.3 (69.1, 93.0) 6.9 (5.0, 9.3) 52.7 (36.3, 73.1)
 200–299 mammograms 85.4 (80.1, 89.8) 12.1 (11.2, 13.1) 35.6 (30.6, 41.0) 81.0 (75.1, 86.1) 7.9 (7.1, 8.7) 36.3 (31.0, 42.1)
 300–499 mammograms 91.3 (88.4, 93.8) 13.0 (12.3, 13.7) 39.0 (35.3, 42.9) 85.7 (81.7, 89.1) 8.5 (7.9, 9.2) 41.7 (37.2, 46.6)
 500–999 mammograms 92.9 (89.5, 95.4) 10.1 (9.3, 10.9) 43.3 (38.5, 48.6) 85.8 (81.5, 89.5) 7.5 (6.9, 8.2) 36.4 (32.2, 41.1)
 1000–1499 mammograms 96.0 (93.2, 98.0) 11.3 (10.5, 12.2) 40.2 (35.4, 45.3) 90.0 (85.6, 93.4) 8.5 (7.8, 9.2) 35.0 (30.5, 39.9)
 1500–1999 mammograms 86.3 (78.7, 92.0) 13.8 (12.3, 15.5) 48.5 (39.2, 59.0) 91.7 (86.5, 95.5) 9.3 (8.5, 10.3) 31.3 (26.4, 36.8)
   2000 mammograms 89.1 (81.7, 94.4) 19.7 (17.4, 22.1) 70.1 (56.4, 85.7) 88.3 (82.0, 93.1) 7.9 (7.0, 8.8) 29.5 (24.4, 35.2)
Average annual screening volume
 480–1000 mammograms 90.7 (86.8, 93.8) 13.6 (12.7, 14.6) 47.7 (42.1, 53.8) 84.4 (79.7, 88.4) 7.4 (6.8, 8.1) 36.3 (31.8, 41.1)
 1000–1499 mammograms 85.3 (79.1, 90.2) 10.9 (10.0, 11.9) 31.9 (26.9, 37.6) 88.2 (82.9, 92.4) 7.8 (7.0, 8.7) 39.5 (33.7, 45.8)
 1500–1999 mammograms 88.0 (82.4, 92.3) 10.5 (9.6, 11.5) 33.0 (28.0, 38.6) 82.2 (75.9, 87.6) 6.2 (5.4, 7.0) 37.0 (31.2, 43.5)
 2000–2999 mammograms 93.8 (91.2, 95.9) 13.7 (12.9, 14.4) 46.4 (42.0, 51.1) 84.2 (80.6, 87.4) 8.2 (7.6, 8.7) 34.6 (31.2, 38.2)
 3000–3999 mammograms 90.1 (86.5, 93.1) 13.9 (13.0, 14.9) 50.0 (44.5, 55.9) 89.8 (86.4, 92.7) 9.2 (8.6, 9.8) 34.0 (30.4, 37.8)
   4000 mammograms 92.7 (88.9, 95.5) 9.8 (9.1, 10.6) 37.9 (33.2, 42.9) 87.9 (82.5, 92.2) 6.5 (5.9, 7.2) 29.3 (24.9, 34.1)
Average annual total volume
 480–1000 mammograms 87.6 (82.5, 91.8) 12.0 (11.1, 13.0) 36.1 (31.0, 41.7) 84.4 (79.0, 89.0) 9.9 (8.9, 11.0) 51.4 (44.2, 59.4)
 1000–1499 mammograms 85.5 (76.5, 92.2) 9.0 (7.8, 10.2) 28.3 (22.0, 35.6) 89.0 (81.1, 94.6) 8.2 (6.9, 9.5) 40.7 (32.2, 50.5)
 1500–1999 mammograms 88.0 (83.0, 92.0) 12.5 (11.6, 13.5) 37.4 (32.2, 43.0) 87.8 (82.5, 92.0) 7.4 (6.6, 8.2) 39.9 (34.1, 46.3)
 2000–2999 mammograms 93.4 (90.2, 95.8) 12.4 (11.6, 13.2) 41.4 (36.9, 46.4) 82.8 (77.9, 87.0) 8.1 (7.4, 8.8) 35.0 (30.7, 39.7)
 3000–4999 mammograms 91.2 (88.3, 93.7) 13.2 (12.4, 14.0) 50.3 (45.5, 55.5) 84.9 (81.4, 88.1) 7.0 (6.6, 7.5) 30.7 (27.8, 33.9)
   5000 mammograms 92.4 (89.5, 94.8) 12.1 (11.4, 12.8) 44.7 (40.4, 49.4) 89.2 (86.0, 91.9) 7.9 (7.4, 8.4) 30.2 (27.2, 33.3)
Average annual diagnostic focus (%)
   5 88.6 (82.5, 93.3) 11.8 (10.7, 13.0) 37.8 (31.4, 44.9) 80.1 (73.0, 86.2) 8.6 (7.5, 9.7) 41.9 (34.8, 49.9)
 6–10 85.2 (68.9, 95.1) 13.3 (10.6, 16.2) 39.3 (25.5, 57.1) 82.5 (68.9, 92.1) 7.6 (6.1, 9.2) 28.4 (19.8, 38.9)
 11–15 89.6 (86.1, 92.6) 12.2 (11.5, 13.0) 37.7 (33.7, 42.0) 83.5 (79.2, 87.4) 6.8 (6.2, 7.4) 37.7 (33.4, 42.3)
 16–20 91.1 (88.0, 93.6) 11.9 (11.3, 12.6) 38.0 (34.3, 42.0) 85.0 (80.7, 88.8) 7.9 (7.3, 8.5) 32.3 (28.5, 36.4)
 21–25 91.6 (88.3, 94.3) 9.4 (8.7, 10.0) 39.2 (35.0, 43.8) 93.2 (89.6, 95.9) 8.8 (7.9, 9.6) 49.9 (43.9, 56.4)
 26–30 92.9 (87.8, 96.4) 16.0 (14.5, 17.6) 59.4 (50.0, 69.8) 87.8 (83.3, 91.6) 10.0 (9.2, 10.8) 36.1 (31.5, 41.2)
  . 30 87.5 (79.5, 93.3) 17.1 (15.1, 19.1) 52.3 (41.7, 64.5) 90.0 (84.1, 94.4) 8.9 (8.1, 9.8) 27.6 (22.9, 32.8)
Note.—Data are estimates, and data in parentheses are 95% CIs. Estimates were obtained by collapsing across all mammograms within the volume stratum, and 95% CIs were calculated by inverting 
a likelihood ratio test. FPR is rate per 100 mammograms, and CDR is rate per 1000 mammograms.
both diagnostic volume and diagnostic 
focus increased; no relationship between 
volume and CDR was found for breast 
concern or problem mammography. 
 The mechanisms by which radiolo-
gists acquire experience and translate 
it into improved diagnostic mammog-
raphy performance are likely complex. 
Particularly challenging is the fact that 
both accrual of experience, for which 
we view radiologist interpretive volume 
as a measurable surrogate, and diag-
nostic performance are multifaceted. 
That both annual diagnostic volume and 
diagnostic focus exhibited the strongest 
evidence of an association suggests that 
a key determinant in developing thresh-
olds for considering diagnostic examina-
tion fi ndings abnormal is the accrual of 
diagnostic mammography experience, as 
opposed to experience in the interpre-
tation of screening mammograms. 
 Both diagnostic volume and diagnos-
tic focus had strong nonlinear relation-
ships with performance: radiologists at 
the extremes of the volume range had 
worse performance for sensitivity and 
better performance for FPR. This may 
refl ect changing mechanisms by which 
increasing diagnostic experience may 
infl uence thresholds for recommending 
biopsy of a suspicious lesion; as diag-
nostic volume or diagnostic focus in-
creases, radiologists are exposed to 
more mammograms obtained in women 
who ultimately receive a breast cancer 
diagnosis. One hypothesis is that radi-
ologists benefi t from this because they 
learn to recognize different abnormal-
ities as benign or malignant and then, 
because they have experience interpret-
ing a broader range of lesions, sensitiv-
ity increases and FPR decreases. How-
ever, the incremental learning benefi t 
may diminish with volume, leading to 
a plateau effect, or it may ultimately be 
detrimental as workload increases to 
very high levels. 
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and Drug Administration regulations 
state that U.S. physicians who interpret 
mammograms must have interpreted 
960 mammograms within the previous 
24 months. The Food and Drug Admin-
istration does not distinguish between 
screening and diagnostic mammogra-
phy for volume requirements. As we 
have found, the relationships between 
continuing experience and diagnostic 
performance are complex, confounding 
regulations based on the simple use of 
did not have self-reported lumps (the 
latter generally are more ambiguous). 
 Buist et al ( 18 ) recently reported on a 
comprehensive study of the association 
between interpretive volume and screen-
ing performance. Radiologists with higher 
annual volume had clinically and sig-
nifi cantly lower FPR with similar sensi-
tivity when compared with radiologists 
with lower volume. In addition, radiolo-
gists with a greater screening focus had 
lower sensitivity, FPR, and CDR. Food 
 We found evidence of signifi cant in-
teraction between the presence of a 
lump and both diagnostic volume and 
diagnostic focus for FPR in mammogra-
phy performed because of a breast con-
cern or problem. Before the study, we 
hypothesized that the skill required to 
examine a lump may be different than 
that required for other concerns and 
that the accrual of experience may be 
more benefi cial to the interpretation of 
mammograms obtained in women who 
 Table 4 
 Estimated Adjusted Odds Ratio Associations between Annual Diagnostic Volume and Diagnostic Performance 
Annual Diagnostic Volume
Sensitivity FPR CDR
Odds Ratio  P  Value * Odds Ratio  P  Value * Odds Ratio  P  Value * 
Additional imaging …  , .001 … .198 … .061
 100 mammograms 0.53 (0.23, 1.21) … 0.83 (0.64, 1.06) … 0.83 (0.64, 1.07) …
 200 mammograms 0.59 (0.29, 1.20) … 0.85 (0.68, 1.05) … 0.85 (0.68, 1.06) …
 300 mammograms 0.65 (0.35, 1.19) … 0.87 (0.72, 1.04) … 0.87 (0.72, 1.04) …
 400 mammograms 0.71 (0.43, 1.17) … 0.89 (0.76, 1.03) … 0.89 (0.76, 1.03) …
 500 mammograms 0.78 (0.52, 1.16) … 0.91 (0.81, 1.02) … 0.90 (0.80, 1.02) …
 1000 mammograms 1.00 (NA) … 1.00 (NA) … 1.00 (NA) …
 1500 mammograms 0.82 (0.69, 0.99) … 1.05 (0.99, 1.12) … 1.09 (1.01, 1.18) …
 2000 mammograms 0.43 (0.29, 0.64) … 1.06 (0.90, 1.25) … 1.19 (0.97, 1.46) …
 2500 mammograms 0.18 (0.08, 0.39) … 1.04 (0.76, 1.43) … 1.28 (0.86, 1.89) …
Breast concern or problem
 No self-reported lump … .049 † … .004 … .244 † 
  100 mammograms 0.50 (0.28, 0.87) … 0.63 (0.47, 0.84) … 0.84 (0.65, 1.10) …
  200 mammograms 0.54 (0.34, 0.88) … 0.67 (0.53, 0.86) … 0.86 (0.69, 1.08) …
  300 mammograms 0.60 (0.39, 0.90) … 0.72 (0.59, 0.89) … 0.88 (0.73, 1.06) …
  400 mammograms 0.65 (0.46, 0.92) … 0.77 (0.65, 0.91) … 0.90 (0.77, 1.05) …
  500 mammograms 0.71 (0.53, 0.93) … 0.82 (0.72, 0.94) … 0.92 (0.82, 1.03) …
  1000 mammograms 1.00 (NA) … 1.00 (NA) … 1.00 (NA) …
  1500 mammograms 1.19 (0.96, 1.47) … 0.93 (0.82, 1.07) … 1.04 (0.94, 1.15) …
  2000 mammograms 1.18 (0.71, 1.95) … 0.66 (0.45, 0.99) … 1.04 (0.75, 1.45) …
  2500 mammograms 1.07 (0.44, 2.58) … 0.41 (0.19, 0.88) … 1.01 (0.53, 1.93) …
 Self-reported lump … NA … .582 … NA
  100 mammograms NA … 0.85 (0.63, 1.16) … NA …
  200 mammograms NA … 0.87 (0.67, 1.14) … NA …
  300 mammograms NA … 0.89 (0.71, 1.12) … NA …
  400 mammograms NA … 0.91 (0.76, 1.09) … NA …
  500 mammograms NA … 0.93 (0.80, 1.07) … NA …
  1000 mammograms NA … 1.00 (NA) … NA …
  1500 mammograms NA … 1.03 (0.95, 1.11) … NA …
  2000 mammograms NA … 1.00 (0.81, 1.24) … NA …
  2500 mammograms NA … 0.95 (0.62, 1.46) … NA …
Note.—Unless otherwise indicated, data are odds ratios, and data in parentheses are 95% CIs. FPR is rate per 100 mammograms, and CDR is rate per 1000 mammograms. For mammography 
performed to evaluate a breast concern or problem, an interaction with self-reported presence of a lump was evaluated. When the interaction was not signifi cant, a main-effects only model was fi t, 
and lump stratum–specifi c estimates were the same. When the interaction was signifi cant, lump stratum–specifi c estimates differed. Results correspond to Figure E4 (online). Sensitivity and CDR data 
were not obtained for women with a self-reported lump because interaction with lump was not signifi cant (see results for No self-reported lump). NA = not applicable.
* Two-sided omnibus  P value for overall association based on natural cubic spline model.
 †  P value for main effects–only model when an interaction between volume and presence of self-reported lump was not signifi cant.
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United States ensures that our results 
are representative of the associations in 
community-based settings ( 15 ). 
 This study suggests that diagnostic 
mammography experience, more im-
mediate feedback generated during the 
diagnostic process, or both may be ben-
efi cial and should be encouraged and 
shared among radiologists. Because 
of the multifaceted nature of interpre-
tive volume and diagnostic perfor-
mance, it is a challenge to characterize 
their relationship and doing so limits 
the practicality of setting regulatory 
thresholds for diagnostic mammographic 
interpretation. 
 Acknowledgments: We thank Rebecca Hughes, 
BA, for editorial assistance and the participat-
ing radiologists, women, and mammography fa-
cilities for the data they have provided for this 
study. A list of the BCSC investigators and pro-
cedures for requesting BCSC data for research 
are provided at  http://breastscreening.cancer
.gov/ . 
to prespecifi ed volume ranges. Although 
the observed associations may be validly 
interpreted within these ranges, the re-
sults may not be generalized to radiolo-
gists with very high volumes. 
 This study also had a number of 
important strengths. Detailed informa-
tion on a large sample of mammograms 
from the BCSC permitted comprehen-
sive characterization of volume and its 
association with diagnostic interpretive 
performance in community-based set-
tings. Our volume data were verifi ed 
by radiology facility records; therefore, 
we did not need to rely on self-reported 
estimates, and we were able to control 
for a number of well-known correlates 
of diagnostic performance. The pro-
spective linkage of radiologist-specifi c 
volume measures with performance in 
the subsequent year strengthens the 
interpretation of our results. Finally, 
the coverage of the BCSC across the 
a lower limit for continuing experience. 
Further, only 33% of diagnostic mam-
mograms for which the radiologist-
given indication was breast concern or 
problem were obtained in women who 
had reported a breast lump. This sug-
gests some examinations performed 
in asymptomatic or quasisymptomatic 
women are routinely being classifi ed 
as diagnostic examinations instead of 
as screening examinations. Regulatory 
thresholds for the number of diagnostic 
mammograms could therefore be easily 
circumvented by lack of adherence to 
strict defi nitions of what constitutes a 
screening examination, rendering the 
threshold ineffective. 
 This study had some limitations. These 
are observational data, and we cannot 
rule out the possibility of residual con-
founding or differences in case mix across 
radiologists and time. Further, because 
of sparse data, we restricted our analyses 
 Table 5 
 Estimated Adjusted Odds Ratio Associations and Annual Diagnostic Focus and Diagnostic Performance 
Sensitivity FPR CDR
Annual Diagnostic Focus Odds Ratio  P Value * Odds Ratio  P  * Odds Ratio  P  * 
Additional imaging (%) … .055 … .024 … .007
 0 0.37 (0.12, 1.13) … 0.65 (0.46, 0.90) … 0.78 (0.52, 1.17) …
 5 0.55 (0.27, 1.14) … 0.75 (0.60, 0.94) … 0.83 (0.63, 1.09) …
 10 0.78 (0.53, 1.15) … 0.85 (0.75, 0.97) … 0.88 (0.76, 1.02) …
 20 1.00 (NA) … 1.00 (NA) … 1.00 (NA) …
 30 0.58 (0.36, 0.93) … 0.97 (0.89, 1.05) … 1.15 (1.03, 1.28) …
 40 0.20 (0.05, 0.75) … 0.84 (0.68, 1.03) … 1.33 (0.98, 1.82) …
Breast concern or problem (%)
 No lump … .661 …  , .001 … .293
  0 0.54 (0.15, 2.02) … 0.60 (0.37, 0.97) … 1.40 (0.72, 2.72) …
  5 0.67 (0.28, 1.58) … 0.74 (0.53, 1.03) … 1.27 (0.81, 2.00) …
  10 0.81 (0.51, 1.28) … 0.88 (0.72, 1.08) … 1.16 (0.90, 1.51) …
  20 1.00 (NA) … 1.00 (NA) … 1.00 (NA) …
  30 0.91 (0.56, 1.47) … 0.74 (0.65, 0.85) … 0.92 (0.81, 1.04) …
  40 0.69 (0.18, 2.68) … 0.43 (0.32, 0.57) … 0.87 (0.62, 1.22) …
 Lump (%) … .051 … .807 … .338
  0 0.48 (0.18, 1.29) … 0.96 (0.57, 1.61) … 1.08 (0.67, 1.72) …
  5 0.58 (0.31, 1.09) … 0.98 (0.69, 1.39) … 1.03 (0.76, 1.40) …
  10 0.69 (0.49, 0.98) … 0.99 (0.81, 1.21) … 1.00 (0.85, 1.17) …
  20 1.00 (NA) … 1.00 (NA) … 1.00 (NA) …
  30 1.47 (0.79, 2.75) … 0.96 (0.86, 1.08) … 1.13 (0.95, 1.35) …
  40 2.19 (0.42, 11.37) … 0.91 (0.67, 1.22) … 1.38 (0.83, 2.29) …
Note.—Unless otherwise indicated, data are odds ratios, and data in parentheses are 95% CIs. FPR is rate per 100 mammograms, and CDR is rate per 1000 mammograms. For breast concern or 
problem mammography, an interaction with self-reported presence of a lump was evaluated and found to be signifi cant; hence, lump stratum–specifi c results are presented. Results correspond to 
Figure E5 (online).
* Two-sided omnibus  P value for overall association based on natural cubic spline model.
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